Neuro-Psychopharmacology. Proceedings of the 11th Congress of the Collegium Internationale Neuro-Psychopharmacologicum, Vienna, July 9–14, 1978

Content: 
Front Matter, Page iii
Copyright, Page iv
C. I. N. P. COMMITTEES, Page xi
11th C. I. N. P. CONGRESS COMMITTEES, Page xii
ACKNOWLEDGEMENTS, Page xiii
Presidential Address, Pages 1-6, LEO E. HOLLISTER
Summary, Pages 9-10, J.-O. OTTOSSON
Long Lasting Effects of ECT on Monoaminergic Mechanisms, Pages 11-20, KJELL MODIGH
Enhanced Monoamine Behavioural Responses Following Repeated Electroconvulsive Shock to Rats and their Relevance to ECT, Pages 21-29, A.R. GREEN, D.W. COSTAIN, D.J. HEAL, C.K. ATTERWILL, D.G. GRAHAME-SMITH
ECT Effects on Mineral Metabolism and Neuroendocrine Function, Pages 31-40, PETER E. STOKES
Convulsive Therapy in Depression: A Neurohumoral and Neuroendocrine Theory, Pages 41-44, MAX FINK
The HLA System and the Celinical Response to Treatment with Haloperidol, Pages 47-53, C.L. CAZZULLO, E. SMERALDI, L. BELLODI, F. NEGRI, P. BONARA
Genetic Components in the Mechanism of Action of Lithium: HLA-Antigens and the Response to Prophylactic Lithium, Pages 55-59, C. PERRIS, E. STRANDMAN, L. WÄHLBY
Genetics and Lithium Ion Metabolism in Affective Disorders, Pages 61-74, J. MENDLEWICZ, P. VERBANCK, P. LINKOWSKI
Pharmacogenetics and the Pharmacologic Challenge Strategy in Clinical Research: Studies of D-Amphetamine and Arecoline, Pages 75-83, E.S. GERSHON, J.N. NURNBERGER, N. SITARAM, J.C. GILLIN
Functional Activitiy of Brain Monoamine Oxidase, Pages 85-94, M.B.H. YOUDIM
Biochemical Genetics and Platelet MAO, Pages 95-101, R.H. BELMAKER, R.P. EBSTEIN
Serotonin in Depressive Illness - Studies of CSF 5-HIAA, Pages 105-115, MARIE ÅSBERG, LEIF BERTILSSON
Obsessive-Compulsive Disorders: A Serotonergic Hypothesis, Pages 117-125, J.A. YARYURA-TOBIAS, F. NEZIROGLU, H.N. BHAGAVAN
Noradrenergic Function in Affective Illness, Pages 127-137, F.K. GOODWIN, W.Z. POTTER
The Case for Involvement of Dopamine in Depression and Mania, Pages 139-150, A. RANDRUP, I. MUNKVAD, R. FOG, C. BRAESTRU, L. MOLANDER
Peptides in Affective Disorders: A Review, Pages 151-161, ARTHUR J. PRANGE Jr., PETER T. LOOSEN, IAN C. WILSON
Biogenic Amine Metabolites in Cerebrospinal Fluid of Patients with Affective Disorders, Pages 163-171, P. VESTERGAARD, T. SØRENSEN, E. HOPPE, O.J. RAFAELSEN, C.M. YATES, N. NICOLAOU
Adenylate Cyclase and the Mechanism of Lithium Action, Pages 173-184, R.H. BELMAKER, R.P. EBSTEIN
An Appraisal of Clinical Studies on the Dopaminergic Hypothesis of Depression, Pages 185-196, A. AGNOLI, S. RUGGIERI
HLA Antigens in Affective Disorders, Pages 197-204, J. MENDLEWICZ, P. VERBANCK, P. LINKOWSKI, A. GOVAERTS
HLA Antigens in Affective Disorders and Cycloid Psychoses, Pages 205-208, C. PERRIS, E. STRANDMAN, L. WÄHLBY
HLA-Antigens in Manic-Melancholic Disorders, Pages 209-213, O.J. RAFAELSEN, P. KRAMP, L.P. RYDER, R.W. SHAPIRO, A. SVEJGAARD
The HLA System as a Possible Marker for Psychiatric Disorders, Pages 215-220, E. SMERALDI, R. SCORZA-SMERALDI, L. BELLODI, G. FABIO, F. NERGI, P. BONARA
Diurnal Rhythms in Manic-Depressive Disorders, Pages 221-231, H. GIEDKE, B. PFLUG
48-Hour-Cycles of Depression and their Biological Concomitants with and without ‘Zeitgebers’. A Case Report, Pages 233-245, D. VON ZERSSEN, R. LUND, P. DOERR, M. FISCHLER, H.M. EMRICH, D. PLOOG
Chronobiological Aspects of Manic-Melancholic Disorders, Pages 247-254, E.T. MELLERUP, H. DAM, ALICE WIDDING, O.J. RAFAELSEN
A New Classification of the Affective Disorders, Pages 255-273, PROFESSOR SIR MARTIN ROTH
General Survey of the Possible Correlations Between Psychiatric Disorders and Biological Modifications, Pages 277-281, E. ZARIFIAN, H. LOO
Blood Platelets as a Model for Brain Neurones: Relevance to Psychiatric Disorders and Mental Abnormalities, Pages 283-302, D.J. BOULLIN
Measurement of Neuro-Transmitter Metabolites in Blood, Urine and CSF in Psychiatric Patients, Pages 303-311, H. BECKMANN
Endocrinological and Peptide Modifications in Psychiatric Illness, Pages 313-321, MICHAEL H. SHEARD
Concluding Remarks, Page 323, H. LOO
Neuropsychopharmacology of Hyperkinetic Children, Pages 327-336, RACHEL GITTELMAN-KLEIN
Neuropsychopharmacology of Childhood Psychoses, Pages 337-347, M. CAMPBELL
Neurophysiology and Child Psychiatry, Pages 349-360, JOVAN SIMEON, BERND SALETU
EEG Effects of Clozapine: Assocation or Dissocation of EEG and Behavior?, Pages 363-369, MAX FINK
Acute Efficacy of 20 Psychotropic Drugs on Human EEG Power Spectrum Variables Shown by Multivariate and Univariate Statistics, Pages 371-381, W.M. HERRMANN, K. FICHTE, T.M. ITIL, St. KUBICKI
Strategy of Statistical Spectral Analysis in Drug Studies. A Methodological Synopsis, Pages 383-391, P. ETEVENON, B. PIDOUX, P. RIOUX
Drawing Inferences about the Therapeutic Efficacy of Drugs in Patients from their CNS Effect in Normals: Comparative Quantitative Pharmaco-EEG and Clinical Investigations, Pages 393-407, B. SALETU, M. SALETU, J. GRÜNBERGER, R. MADER
Chronospectrogram Analysis in the Assessment of Spontaneous and Drug-induced Changes in Vigilance, Pages 409-416, M. MATEJCEK
Quantitative EEG in Relation to Plasma Concentration During Treatment with Antiepileptic Drugs, Pages 417-425, G. ROSADINI, W.G. SANNITA
Naltrexone in Normal Men, Pages 427-433, J. VOLAVKA, A. MALLYA, J. PEVNICK, D. CHO, D. REKER, B. JAMES, J. BAUMAN, R. DORNBUSH
Introduction, Pages 437-438, EVE C. JOHNSTONE
ACTH as a Mediator in Anxiety, Pages 439-448, SANDRA E. FILE
Effects of Benzodiazepines on the Electrical Activity of the Central Nervous System: Correlation with Synaptic Pharmacology, Pages 449-458, W. HAEFELY, P. POLC, L. PIERI, R. SCHAFFNER
Diazepam Metabolism in Healthy Subjects and Patients with Heart Failure, Renal Failure, and Hepatic Cirrhosis, Pages 459-466, L. HILLESTAD, T. HANSEN
The Differentiation Between Neurotic Depression and Anxiety and Drug Treatment, Pages 467-472, K. RICKELS, R. DOWNING, M. STEIN
The Phenomenological, Pharmacological and Psychophysiological Characteristics of Neurotic Outpatients to whom no Diagnosis has been Applied, Pages 473-477, C.D. FRITH, EVE C. JOHNSTONE, D. OWENS, K. McPHERSON
Prediction of Response to Anti-Anxiety Agents, Pages 481-487, C. HALLSTRÖM, M. LADER
Provocative Pharmacological Agents for Psychiatric Diagnosis: Methylphenidate, Sodium Amobarbital and Physostigmine, Pages 489-495, J. JANOWSKY, J. DAVIS, M. DYSKEN, G. KILLIAN
Summary of Symposium on “Endorphins”, Pages 499-501, ERMINIO COSTA
Possible Function of β Endorphin, Pages 503-514, J.W. HOLADAY, G.L. BELENKY, A.I. FADEN, H.H. LOH
Beta-Endorphin Modulates Cholinergic and GABA-ergic Neurotransmission, Pages 515-525, F. MORONI
Studies on a Possible Pathological Significance of Endorphins in Psychiatric Disorders, Pages 527-534, H.M. EMRICH, V. HÖLLT, H. LASPE, M. FISCHLER, H. HEINEMANN, W. KISSLING, D.V. ZERSSEN, A. HERZ
Beta-Endorphins and Naloxone in Psychiatric Patients: Clinical and Biological Effects, Pages 535-539, H.E. LEHMANN, TH. COOPER, N.P.V. NAIR, N.S. KLINE
The Interaction of Naloxone with Striatal Dopaminergic Mechanisms, Pages 541-552, JEFFEREY FEIGENBAUM, BYONG MOON, HAROLD KLAWANS
Chairman's Introductory Remarks, Pages 555-558, PAOLO L. MORSELLI
Pharmacokinetics and Pharmacodynamics of Haloperidol in Man, Pages 559-565, A. FORSMAN, R. ÖHMAN
Monitoring of Phenothiazine Plasma Levels in Psychiatric Patients, Pages 567-575, SVEIN G. DAHL
Plasma Level Monitoring of Tricyclic Antidepressants: Usefulness and Limitations, Pages 577-583, LARS F. GRAM
Biological Monitoring of Psychotropic Drug Treatment: Usefulness and Limitations, Pages 585-590, MALCOLM LADER
Quantitative EEG, Drug Levels and Clinical Effects, Pages 591-598, P. ETEVENON
Concluding Remarks, Pages 599-600, PIERRE DENIKER
Introduction, Pages 603-610, RYO TAKAHASHI, HARUO NAGAYAMA
The Influence of Dopaminergic Mechanism on 24-Hour Temperature and Activity Rhythms in Rodents, Pages 611-620, J.A. DAVIES
The Influnce of the 24-Hour Rhythm in Brain 5HT on Response to Tryptophan and NN-Diemethyltryptamine, Pages 621-628, F. BROWN, J. NICHOLASS, P.H. REDFERN
Chronobiology, A New Perspective for Biology and Medicine, Pages 629-646, LAWRENCE E. SCHEVING
Circadian Susceptibility Rhythm to Neuroleptics, Pages 647-651, HARUO NAGAYAMA, AKINORI TAKAGI, KENZABURO NISHIWAKI, RYO TAKAHASHI
Transmitter Precursor Loading - Uses and Limitations, Pages 655-660, G. CURZON
Behavioural Responses to L-Tryptophan and L-Dopa in Monoamine Oxidase Inhibitor Treated Rats, Pages 661-669, A.R. GREEN, J.F.W. DEAKIN, D.W. COSTAIN
Symposium on Behavioural Effects of Indoleamine and Catecholamine Precusors: Summary, Pages 671-672, G. CURZON
Opiate Addiction - New Perspectives in Research, Pages 675-685, RÜDIGER SCHULZ, ALBERT HERZ
Pharmacological Basis of Clinical Abuse of Sedative Drugs, Pages 687-697, H. COPER, G. STILLE
Reinforcement Mechanisms of Stimulant Drugs, Pages 699-712, L.P. GONZALEZ, E.H. ELLINWOOD Jr.
Present Use of Hallucinogens, Pages 713-719, LEO E. HOLLISTER
The Summaries of the Symposia: A Synthesis, Pages 721-728, MARTIN ROTH
Index, Pages 729-736